Observational studyBMC infectious diseases2025
Epidemiological and clinical characteristics of bacterial co-detection in respiratory syncytial virus-positive children in Wenzhou, China, 2021 to 2023.
Observational study in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Differential associations of pathogen-specific co-infections with disease severity in pediatric RSV hospitalizations: a 3-year multicenter analysis.Microbiology spectrum · 2026Article
- Impact of Respiratory Viral Codetections on RSV Disease Burden in Young Children in Primary Care.Influenza and other respiratory viruses · 2026Article
- Viral-bacterial codetection and clinical and laboratory characteristics in children hospitalized with lower respiratory tract infections in a private hospital in Lima, Peru: a cross-sectional study.Tropical diseases, travel medicine and vaccines · 2026Article
- A Clinical Prediction Model for Bacterial Coinfection in Children with Respiratory Syncytial Virus Infection: A Development and Validation Study.Diagnostics (Basel, Switzerland) · 2026Article
- Research on age-stratified prevention and control strategies for pediatric RSV infection based on disease burden disparities.BMC infectious diseases · 2026Article
- Epidemiology of human RSV in Taiwan, 2018-2024.PloS one · 2026Article
- Epidemiology and clinical impact of pediatric RSV co-infections after the COVID-19 pandemic: a narrative review.Frontiers in pediatrics · 2026Review
- RSV-infected children with mixed infections: clinical features and early predictive indicators of codetection withFrontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRespiratory syncytial virus (RSV) is a leading cause of respiratory tract infections in young children, posing significant health challenges worldwide. This study aims to analyze the etiological, clinical, and imaging characteristics of RSV infection in children from Wenzhou, China, to better understand its epidemiological profile and provide insights for early diagnosis, monitoring, and clinical interventions.
methodsThis retrospective descriptive observational study included 1,063 RSV-positive pediatric inpatients (< 14 years) from the Second Affiliated Hospital of Wenzhou Medical University (December, 2021, and April, 2023). Missing data were addressed using multiple imputation. Patients were grouped by co-infection type (viral or bacterial), and differences in demographic, clinical, and imaging features were analyzed. Univariate and multivariate logistic regression identified risk factors for bacterial co-infection in RSV-positive patients. Predictive features were selected via the Boruta algorithm and modeled using XGBoost, with SHAP applied for interpretability. Pathogen distributions were also compared across age groups in both co-infection subtypes.
resultsAmong 1,063 hospitalized RSV-positive children, RSV primarily affected those under one year of age, with a substantial proportion of cases (47.3%) showing co-infections. The most frequently detected viral co-pathogen was human rhinovirus (HRV, 42.2%), while Streptococcus pneumoniae (37.3%) was the most common bacterial pathogen. Some children were found to carry multiple pathogens simultaneously. Age-stratified radiographic analysis revealed that bronchitis was the predominant imaging finding across all age groups. Compared with the viral co-infection group, children with bacterial co-infections had longer hospital stays (6.4 vs. 5.4 days), higher white blood cell and neutrophil counts, and lower IgE levels (P < 0.05). Logistic regression analysis identified length of stay, prealbumin (PA), and immunoglobulin E (IgE) as independent predictors of bacterial co-infection. Feature selection using the Boruta algorithm, combined with XGBoost modeling and SHAP interpretation, further confirmed that length of stay, WBC count, neutrophil count, and IgE were the most important predictive variables. Age-specific pathogen analysis showed that influenza A and Streptococcus pneumoniae were predominantly found in children aged 3 to < 6 years (P < 0.05).
conclusionsRSV infections in Wenzhou predominantly occur in infants under one year of age and frequently involve co-infections with viruses and bacteria, particularly rhinovirus and Streptococcus pneumoniae. Early identification of co-infections and tailored interventions are critical to improving patient outcomes.
trial registrationNot applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.